Drug–drug interaction through molecular structure similarity analysis

BACKGROUND: Drug–drug interactions (DDIs) are responsible for many serious adverse events; their detection is crucial for patient safety but is very challenging. Currently, the US Food and Drug Administration and pharmaceutical companies are showing great interest in the development of improved tool...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Vilar, Santiago, Harpaz, Rave, Uriarte, Eugenio, Santana, Lourdes, Rabadan, Raul, Friedman, Carol
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2012
Témata:
Research and Applications
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3534468/
https://ncbi.nlm.nih.gov/pubmed/22647690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/amiajnl-2012-000935
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky